Walker Neal 4

4 · Aclaris Therapeutics, Inc. · Filed Feb 6, 2026

AI-generated summary of this filing

Updated Feb 6, 2026

Aclaris (ACRS) CEO Walker Neal Receives RSU Awards

What Happened

Walker Neal, CEO and Director of Aclaris Therapeutics (ACRS), was granted two restricted stock unit (RSU) awards on Feb 2, 2026: 274,800 RSUs and 961,700 RSUs, for a total of 1,236,500 RSUs. The grants are recorded at $0.00 per unit on the Form 4 (derivative awards), meaning no cash changed hands at grant.

Key Details

Transaction date: February 2, 2026; Form 4 filed February 6, 2026 (appears to be filed after the typical 2-business-day window).
Grant amounts: 274,800 RSUs and 961,700 RSUs (total 1,236,500 RSUs); price reported: $0.00 per unit.
Shares owned after transaction: Not specified in the provided filing details.
Footnotes from the filing:
- F1: Each RSU represents a contingent right to receive one share of common stock.
- F2: These RSUs vest in four equal installments on the 1st, 2nd, 3rd and 4th anniversaries of Feb 2, 2026, subject to continuous service.
- F3: The filing also describes a standard option vesting pattern (25% at first anniversary, then equal installments annually) — relevant if options were part of other awards.
Filing timeliness: The Form 4 was filed four days after the transaction date, which appears later than the usual two-business-day filing requirement.

Context

These are compensation awards (RSUs), not open-market purchases or sales. RSUs give the holder a future right to shares if vesting conditions are met and generally do not result in immediate proceeds or share sales. Such awards are common executive compensation; they increase potential future share holdings if vested but do not by themselves indicate a buy/sell decision in the market.

Form 4

Period: 2026-02-02

DirectorCEO

Transactions

Award
Restricted Stock Units
[F1][F2]
2026-02-02+274,800→ 274,800 total
→ Common Stock (274,800 underlying)
Award
Employee Stock Option (Right to Buy)
[F3]
2026-02-02+961,700→ 961,700 total
Exercise: $3.61Exp: 2036-02-01→ Common Stock (961,700 underlying)

Footnotes (3)

[F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
[F2]The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
[F3]Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.

Signature

/s/ Matthew Rothman, Attorney-in-Fact|2026-02-06

1 file